Clinical Characteristics Matrix of Lung Tumor Under Stereotactic Ablative Body Radiotherapy (SABR)

被引:0
|
作者
Li, K. [1 ]
Jung, E. [2 ]
Wu, B. [3 ]
Mousli, A. [4 ]
Aoki, S. [5 ]
Newton, J. [2 ]
Able, A. [6 ]
Cornell, D. [2 ]
Lee, N. [7 ]
Lo, S. [8 ]
机构
[1] Associates Med Phys, John R Marsh Canc Ctr, Hagerstown, MD USA
[2] John R Marsh Canc Ctr, Radiat Oncol, Hagerstown, MD USA
[3] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA
[4] St Elisabeth, Radiat Oncol, Pl Louise Godin, Namur, Belgium
[5] Univ Tokyo Hosp, Dept Radiol, Tokyo, Japan
[6] Associates Med Phys, Radiat Oncol, Lanham, MD USA
[7] Georgetown Univ, Georgetown, Guyana
[8] Univ Washington, Med Ctr, Radiat Oncol Ctr, Seattle, WA 98195 USA
关键词
Characteristic Matrix; Stereotactic ablative radiotherapy; Similarity Matching;
D O I
10.1016/j.jtho.2017.09.1781
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.14-008
引用
收藏
页码:S2333 / S2333
页数:1
相关论文
共 50 条
  • [41] Quality of Life and Symptoms in Patients Undergoing Stereotactic Ablative Body Radiotherapy (SABR) for Early Stage Lung Cancer
    Gray, C.
    Wingate, E.
    Ghafoor, Q.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (06) : E56 - E56
  • [42] Our experience in treating lung tumours using stereotactic ablative body radiotherapy (SABR) at Northampton General Hospital
    Yusof, H.
    Gore, A.
    Mak, C. I.
    Eldeeb, H.
    Vaidya, D.
    Acquah, H.
    Whilde, N.
    [J]. LUNG CANCER, 2015, 87 : S46 - S46
  • [43] SMALL BOWEL TOLERANCE IN STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR)
    Faria, Sergio
    Kopek, Neil
    Ashram, Samaher
    Patrocinio, Horacio
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S97 - S97
  • [44] IAEA RCA 6065: IMPROVING ACCESS TO STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) FOR LUNG CANCER PATIENTS IN ASIA
    Hegi-Johnson, Fiona
    Siva, Shankar
    Foote, Matthew
    Tan, Daniel
    Kim, Mi-Sook
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1130 - S1130
  • [45] Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer
    Abbas, Ghulam
    Danish, Adnan
    Krasna, Mark J.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 553 - +
  • [46] Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
    Byung-Han Rhieu
    Amol K. Narang
    Jeffrey Meyer
    [J]. Current Hepatology Reports, 2018, 17 (4) : 392 - 398
  • [47] Stereotactic Ablative Radiotherapy (SABR) for Pulmonary Oligometastases and Oligoprogression
    Helou, Joelle
    Thibault, Isabelle
    Yeung, Latifa L.
    Poon, Ian
    Tjong, Michael
    Chiang, Andrew
    Jain, Suneil
    Soliman, Hany
    Cheung, Patrick
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S636 - S636
  • [48] Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
    Chaudhuri, Aadel A.
    Tang, Chad
    Binkley, Michael S.
    Jin, Michelle
    Wynne, Jacob F.
    von Eyben, Rie
    Hara, Wendy Y.
    Trakul, Nicholas
    Loo, Billy W., Jr.
    Diehn, Maximilian
    [J]. LUNG CANCER, 2015, 89 (01) : 50 - 56
  • [49] Influence of Dose and Fractionation on Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR)
    Ross, J. B.
    Ross, J. B.
    Merriott, D. J.
    Alhumaid, S.
    Schueler, E.
    Ko, R. B.
    Bush, K.
    Maxim, P. G.
    Gensheimer, M. F.
    Loo, B. W., Jr.
    Diehn, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E527 - E528
  • [50] Ablative or Palliative Stereotactic Body Radiotherapy with Helical Tomotherapy for Primary or Metastatic Lung Tumor
    Marcenaro, Michela
    Vagge, Stefano
    Belgioia, Leliana
    Agnese, Dario
    Lamanna, Giorgio
    Mantero, Elisa
    Gusinu, Marco
    Garelli, Stefania
    Cavagnetto, Francesca
    Agostinelli, Stefano
    Corvo, Renzo
    [J]. ANTICANCER RESEARCH, 2013, 33 (02) : 655 - 660